Vikrant Shrotriya, Novo Nordisk India MD responds to questions on future pricing, generics competition post patent expiry in March, Indian-specific…
Vikrant Shrotriya, Novo Nordisk India MD responds to questions on future pricing, generics competition post patent expiry in March, Indian-specific…
The class of GLP-1 agonist medications act by lowering the appetite with applications way beyond diabetes. These medicines will be…
In an impassionate address at ‘Telangana Rising Global Summit’ in Hyderabad, Eric Swider, director Trump Media & Technology Group, described…
Extreme weather events, says an RBI report, could reduce India’s GDP by 2 per cent to 6 per cent annually…
Biocon Limited (which holds around 78 per cent) will acquire the remaining stake in Biocon Biologics through a share swap…
Nothing that the central bank does today can apparently go wrong. Both a rate cut or a rate pause can…
The launch of the PLI Scheme for Bulk Drugs in 2020 reignited the hopes to rebuild the country’s pharmaceutical raw…
Kirthiga Reddy, a seasoned practitioner in tech-led transformation and the former managing director of Facebook India (Meta) sees the journey…
There is much to be learnt for the insurance sector, particularly by the private sector insurers, from endeavours like the…
The summit will see some of the leading and finest minds brainstorm, share insights and swap ideas at this rather…
High levels of pollutants in the atmosphere can exacerbate respiratory ailments, cause irritation in the eyes & left unchecked, this…
Commerce and industry minister Piyush Goyal describes the deal as one that showcases India’s healthcare delivery system continuing to strengthen…
Gold is a safe haven in times of uncertainty, but if gold prices reach very high levels, as they have…
Concerns remain as the treatment of chemical intermediates and patented medicines is still not clear
If there are huge manufacturing process deviations & a known culprit each time over the past four decades, then how…
Hospitals expect an 8–10% rise in CGHS billings after the recent rate revision, though many remain cautious, awaiting clarity on…
Govindrajan was revered by all albeit each one either knew him or had known of him differently. To those from…
Dr Anantha Nageswaran also pointed to efforts within the government to move on the path to deregulation with a sense…